Additionally, paracrine CCL2 from F. nucleatum-reprogrammed adipocytes upregulates SLC1A5 and SLC7A11 in head and neck squamous cell carcinoma (HNSCC), leading to glutathione (GSH) accumulation and cisplatin resistance. Here, CCL2 is linked to head and neck squamous cell carcinoma.